Verification evidence is still being completed.
Gensinta UAB
Vilnius, Lithuania
- Verified lead
- Benas Macijauskas
- Lead status
- STATUS: VERIFIED APRIL 2026
- Leadership verification
- Chief Executive Officer
- 2026 technical specialization
- Synthetic Biology, Photonics-Based DNA Synthesis, and Next-Generation Genomics Tools
- Review cycle
- 24 April 2026
- Full address
- Vilnius City Innovation Industrial Park (Northtown), Vilnius, Lithuania
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Northtown Vilnius announcement naming Benas Macijauskas as CEO of Gensinta.
- Editorial note
- Vilnius synthetic biology startup with named CEO, Northtown Innovation Industrial Park tenancy, and photonics-based DNA synthesis technology.
Synthetic Biology, Photonics-Based DNA Synthesis, and Next-Generation Genomics Tools
LithuaniaBIO association member, Vilnius City Innovation Industrial Park tenancy, Public CEO disclosure
Vilnius synthetic biology startup with named CEO, Northtown Innovation Industrial Park tenancy, and photonics-based DNA synthesis technology.
Vilnius synthetic biology startup with named CEO, Northtown Innovation Industrial Park tenancy, and photonics-based DNA synthesis technology.
- Lead
- Benas Macijauskas (verified ↗)
- Address
- Vilnius City Innovation Industrial Park (Northtown), Vilnius, Lithuania (source ↗)
- Compliance
- Not yet on record
- Last reviewed
- 24 Apr 2026 (1mo ago)
- Scale
- Synthetic biology tools R&D
- Capabilities
- New-Generation DNA Synthesis · Molecular Biology and Photonics Integration · Synthetic Biology R&D
- Founded
- 2019
- Headcount
- 1-10
Benas Macijauskas
Chief Executive Officer
Synthetic biology tools R&D
Vilnius, Lithuania. Synthetic Biology, Photonics-Based DNA Synthesis, and Next-Generation Genomics Tools. Review completed on 24 Apr 2026.
Lithuanian innovation authorities for startup support
LithuaniaBIO association member, Vilnius City Innovation Industrial Park tenancy, Public CEO disclosure
Synthetic Biology, Photonics-Based DNA Synthesis, and Next-Generation Genomics Tools
Vilnius synthetic biology startup with named CEO, Northtown Innovation Industrial Park tenancy, and photonics-based DNA synthesis technology.
Gensinta is a Vilnius synthetic biology startup with a named CEO, Vilnius City Innovation Industrial Park tenancy, and active LithuaniaBIO association membership.
Core capabilities
Primary declared technical activities and areas of operating focus.
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Declared infrastructure
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Frequently asked questions
- Where is Gensinta UAB located?
- Gensinta UAB operates from Vilnius City Innovation Industrial Park (Northtown), Vilnius, Lithuania, Vilnius, Lithuania.
- Who runs Gensinta UAB?
- Gensinta UAB is led by Benas Macijauskas, Chief Executive Officer. Verified 24 Apr 2026.
- What does Gensinta UAB do?
- Vilnius synthetic biology startup with named CEO, Northtown Innovation Industrial Park tenancy, and photonics-based DNA synthesis technology. Core capabilities: New-Generation DNA Synthesis, Molecular Biology and Photonics Integration, Synthetic Biology R&D.
Related technical briefs
Briefs that name Vilnius as a covered market or city.
